Acarbose/Metformin Hydrochloride

阿卡波糖/盐酸二甲双胍

Report date: 2025/03/06 20:00:09

Base Information

Drug NameAcarbose/Metformin Hydrochloride
Drug Alias Name盐酸二甲双胍/阿卡波糖Metformin Hydrochloride and AcarboseAcarbose and Metformin HydrochlorideAcarbose/MetforminMetformin Hydrochloride/Acarbose +[7] 
ClassificationSmall molecules
Mechanisms of ActionProtein kinase AMP-activated non-catalytic subunit beta 1 activatorsMaltase-glucoamylase inhibitors
TargetsMaltase-glucoamylaseProtein kinase AMP-activated non-catalytic subunit beta 1
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes AcarboseMetformin Hydrochloride
Global Highest StatusApproved
Highest Status in ChinaPending
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesBayer AG
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeA10BD17
Related LinksN/A